Live Breaking News & Updates on Satsuma Pharmaceuticals Inc

Stay updated with breaking news from Satsuma pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Satsuma Pharmaceuticals : Termination of Material Agreement - Form 8-K

8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

. | June 8, 2023 ....

United States , State Of Delaware , Thomasb King , Tom Soloway , Shinji Nitanda , Mutya Harsch , Shunji Haruta , Michael Riebe , Rajeev Shah , John Kollins , Ken Takanashi , Heath Lukatch , Tom Oneil , Shuichi Kanazashi , Akihisa Mori , Ryoichi Nagata , Merger The Surviving Corporation , Certificate Of Incorporation The Company , Virtu Americas , American Stock Transfer Trust Company , Exchange Commission On , Securities Exchange , Company Current Report On Form , Corporation Law Of The State Delaware , Company The Merger , Satsuma Pharmaceuticals Inc ,

Form SC 14D9/A Satsuma Pharmaceuticals, Filed by: Satsuma Pharmaceuticals, Inc.

Form SC 14D9/A Satsuma Pharmaceuticals, Filed by: Satsuma Pharmaceuticals, Inc.
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Satsuma Pharmaceuticals Inc , Shin Nippon Biomedical Laboratories Ltd , Exchange Commission On , Merger Sub Inc , Recommendation Statement , Satsuma Pharmaceuticals , Exchange Commission , Shin Nippon Biomedical Laboratories , Merger Agreement , Tender Offer Statement , Final Results , Expiration Date , American Stock Transfer , Trust Company , Guaranteed Delivery , All Shares , Merger Consideration , Nasdaq Global Market ,

Form 8-K Satsuma Pharmaceuticals, For: Jun 06

Form 8-K Satsuma Pharmaceuticals, For: Jun 06
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , State Of Delaware , Shunji Haruta , Heath Lukatch , Shuichi Kanazashi , Michael Riebe , Tom Soloway , Shinji Nitanda , Akihisa Mori , Ryoichi Nagata , Rajeev Shah , Mutya Harsch , Ken Takanashi , John Kollins , Thomasb King , Securities Exchange , Company Current Report On Form , Virtu Americas , Company On , Satsuma Pharmaceuticals Inc , Shin Nippon Biomedical Laboratories Ltd , Exchange Commission On , Merger Sub Inc , Merger The Surviving Corporation , Company The Merger , Corporation Law Of The State Delaware ,

Ken Takanashi Purchases 22,053,581 Shares of Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) Stock

Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA – Get Rating) Director Ken Takanashi purchased 22,053,581 shares of the business’s stock in a transaction that occurred on Tuesday, June 6th. The stock was bought at an average price of $0.91 per share, for a total transaction of $20,068,758.71. Following the purchase, the director now directly owns 24,847,694 shares in […] ....

United States , Ken Takanashi , News Ratings For Satsuma Pharmaceuticals Daily , Satsuma Pharmaceuticals , America Corp , Institutional Trading Of Satsuma Pharmaceuticals , Satsuma Pharmaceuticals Stock Performance , Investment Advisers , Satsuma Pharmaceuticals Inc , Millennium Management , Get Rating , Director Ken Takanashi , Sigma Advisers , Two Sigma Investments , Sigma Investments , Satsuma Pharmaceuticals Daily , Nasdaq Stsa , Insider Trading , Nsider Trades ,

New York Mortgage Trust, Inc. (NASDAQ:NYMTN) Declares Quarterly Dividend of $0.50

Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA – Get Rating) Director Ken Takanashi acquired 22,053,581 shares of Satsuma Pharmaceuticals stock in a transaction dated Tuesday, June 6th. The shares were purchased at an average price of $0.91 per share, with a total value of $20,068,758.71. Following the acquisition, the director now owns 24,847,694 shares of the company’s stock, […] ....

Ken Takanashi , Satsuma Pharmaceuticals Stock Performance , Institutional Investors Weigh In On Satsuma Pharmaceuticals , Satsuma Pharmaceuticals , Satsuma Pharmaceuticals Company Profile , Capital Management , Vanguard Group Inc , Walleye Capital , Satsuma Pharmaceuticals Inc , Renaissance Technologies , News Ratings For Satsuma Pharmaceuticals Daily , Get Rating , Director Ken Takanashi , Sigma Investments , Satsuma Pharmaceuticals Daily ,